Key result
Higher cardiometabolic index was independently associated with high-risk high-sensitivity C-reactive protein levels (>3.0 mg/L) in US adults (adjusted OR 1.11; 95% CI 1.03-1.19; p=0.007).
Why the study?
The cardiometabolic index is associated with metabolic and cardiovascular outcomes, but its direct relationship with high-sensitivity C-reactive protein remains unclear.
Is the cardiometabolic index associated with high-risk high-sensitivity C-reactive protein levels in US adults?
Cross-Sectional (n=3,970)
Is the cardiometabolic index associated with high-risk high-sensitivity C-reactive protein levels in US adults?
Effect estimate: OR 1.11 (95% CI 1.03-1.19)
p-value: p=0.007
The cardiometabolic index is significantly associated with elevated hs-CRP levels, highlighting its potential utility as a marker for chronic inflammation related to cardiometabolic risk.
May flag chronic inflammation in cardiometabolic assessment; hypothesis-generating and should not yet change practice.
Objective High-sensitivity C-reactive protein, a key inflammatory biomarker, can indicate the risk of cardiovascular diseases. The cardiometabolic index has been associated with metabolic and cardiovascular outcomes; however, its direct relationship with high-sensitivity C-reactive protein remains unclear. This study aimed to explore this association and identify influencing factors in adult population. Methods This retrospective cross-sectional study used data from the 2015–2018 National Health and Nutrition Examination Survey. A multivariate logistic regression model was applied to assess the association between cardiometabolic index and high-sensitivity C-reactive protein levels (>3.0 mg/L) in 3970 adults, with adjustment for demographic characteristics, comorbidities, and lifestyle factors. Results Cardiometabolic index was independently associated with high-risk high-sensitivity C-reactive protein (adjusted odds ratio = 1.11, 95% confidence interval: 1.03–1.19, p = 0.007). Subgroup analyses indicated that the association was more pronounced in females and non-Hispanic Black participants (p values for interaction were <0.001 and 0.004, respectively). Restricted cubic spline curves confirmed a nonlinear relationship between cardiometabolic index and high-risk high-sensitivity C-reactive protein (nonlinearity p < 0.001). Conclusion Cardiometabolic index demonstrated a significant positive association with high-risk high-sensitivity C-reactive protein in US adults, serving as a marker linking cardiometabolic status to chronic inflammation. Further studies are needed to validate causality and explore cardiometabolic index–guided prevention.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) conducted a cross-sectional in Chronic inflammation (n=3,970). Cardiometabolic index was evaluated on High-risk high-sensitivity C-reactive protein levels (>3.0 mg/L) (OR 1.11, 95% CI 1.03-1.19, p=0.007). Higher cardiometabolic index was independently associated with high-risk high-sensitivity C-reactive protein levels (>3.0 mg/L) in US adults (adjusted OR 1.11; 95% CI 1.03-1.19; p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: